An interview with Emil Kakkis, MD, PhD, founder and CEO of Ultragenyx

Episode 40,   Jul 20, 2022, 02:54 PM

Headliner
Share
Subscribe

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Emil Kakkis, MD, PhD, founder and CEO of San Francisco-based Ultragenyx, on the increasingly complex challenges facing developers of drugs to treat rare diseases.

Share
Subscribe
Next
An interview with cattle rancher Paul Heaton of the Calves2Cure DMD initiative
Top episodes
An Interview WIth Tracy Sharp, a Patient With Lambert-Eaton Myasthenic Syndrome
by Rare Care Podcast
A Discussion on Medullary Thyroid Carcinoma With Dr. David Goldenberg
by Rare Care Podcast
An Interview With Omer Abdul Hamid, MD, of Nemours Children's Hospital in Orlando, Florida
by Rare Care Podcast